Related Experiment Video
Updated: May 10, 2026
07:15
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Toll-like receptors and human disease: lessons from single nucleotide polymorphisms
Yi-Tzu Lin1, Amanda Verma, Conrad P Hodgkinson
1Department of Medicine, Duke University Medical Center & Mandel Center for Hypertension and Atherosclerosis Research, Durham, NC 27710, USA.
Current Genomics
|June 5, 2013
Summary
Genetic variations in Toll-like receptors (TLRs), crucial for innate immunity, are linked to diseases like sepsis and asthma. This review explores how these genetic changes impact TLR function and disease development.
Area of Science:
- Immunology
- Genetics
Background:
- Toll-like receptors (TLRs) are vital proteins for the innate immune system, recognizing pathogen-associated molecular patterns.
- Genetic variations, specifically single nucleotide polymorphisms (SNPs), have been identified within TLRs and their signaling pathways.
Purpose of the Study:
- To review the impact of genetic variation on Toll-like receptor function.
- To explore the role of these genetic variations in the development of various human diseases.
Main Methods:
- Literature review of studies investigating TLRs and genetic polymorphisms.
- Analysis of the functional consequences of identified genetic variations.
- Correlation of genetic variations with disease prevalence and severity.
Main Results:
- Genetic variations in TLRs can alter their recognition of pathogen-associated molecular patterns.
- These alterations can lead to dysregulated immune responses.
- Specific polymorphisms are associated with increased susceptibility to diseases such as atherosclerosis, sepsis, asthma, and immunodeficiency.
Conclusions:
- Genetic variation significantly influences Toll-like receptor function.
- These functional changes are implicated in the pathogenesis of numerous human diseases.
- Understanding these genetic links is crucial for disease prevention and treatment strategies.
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...